Ben and Catherine Ivy Foundation

What they fund

paymentawardadulttranslationalgliomaglioblastomatumorresearch

Funding pattern

What this funder pays for, at what size, and how to position adjacent work. Read from their filings, with every number checked against the record.

1 grant matching “workforce development” · $520,000

• $520,000

  Maricopa Community Colleges Foundat · Tempe, AZ · 2024

  Nursing workforce development program.

Top recipients

Repeat recipients are the strongest signal of whether a funder has an open door or quietly re-funds the same organizations.

• Neuro Trials Llc10 grants · $22.4M
• Neurotrials Llc4 grants · $8.6M
• St Joseph'S Foundation6 grants · $7.9M
• Society of St Vincent De Paul3 grants · $1.6M
• Johns Hopkins Hospital5 grants · $1.4M
• City of Hope Medical Center4 grants · $1.2M
• University of Tx Md Anderson Cancer5 grants · $1.1M
• Vanguard Charitable2 grants · $950,000
• University of Virginia3 grants · $900,000
• Rector Visitors of Univ of Va3 grants · $900,000

Giving over time

Grant history

The 100 largest of 153 grants.

• $6.0M

  St Joseph'S Foundation · Phoenix, AZ · 2023

  Ivy brain tumor center at barrow neurological institute capital expenditures.

• $5.5M

  Neurotrials Llc · Phoenix, AZ · 2022

  Prepayment of 2023 cerebrospinal fluid analysis.

• $5.0M

  Neuro Trials Llc · Phoenix, AZ · 2022

  Ivy brain tumor center building expansion special grant amendment.

• $4.3M

  Neuro Trials Llc · Phoenix, AZ · 2025

  Special grant - funding for employment and special needs.

• $3.8M

  Neuro Trials Llc · Phoenix, AZ · 2023

  Multiple awards:1) development of triple-drug cocktails to induce glioblastoma.2) ucsf preclinical core for drug development at the ivy brain tumor center.3)10 year ibtc grant4) matching funds national gbm day

• $2.8M

  Neuro Trials Llc · Phoenix, AZ · 2024

  7th installment payment for theivy brain tumor center.

• $2.8M

  Neuro Trials Llc · Phoenix, AZ · 2025

  8th installment payment for theivy brain tumor center.

• $2.3M

  Neurotrials Llc · Phoenix, AZ · 2025

  Building expansion - payment #5

• $1.6M

  Neuro Trials Llc · Phoenix, AZ · 2025

  Cerebrospinal fluid analysis.

• $1.4M

  Neuro Trials Llc · Phoenix, AZ · 2024

  Cerebrospinal fluid analysis. (3rd payment)

• $1.0M

  Society of St Vincent De Paul · Phoenix, AZ · 2024

  Center for purpose, hope and mission as part of the common ground.

• $925,000

  Vanguard Charitable · Warwick, RI · 2024

  Making philanthropy as effective and efficient as possible, ensuring that charitable dollars are used wisely and that their impact is maximized.

• $900,000

  St Joseph'S Foundation · Phoenix, AZ · 2024

  St. Joseph's lobby remodel.

• $714,675

  Phoenix Police Foundation · Phoenix, AZ · 2024

  For specific needs.

• $525,000

  St Joseph'S Foundation · Phoenix, AZ · 2024

  Lab chemistry analyzers, pathology lab slide stainer, hematology analyzer.

• $520,000

  Maricopa Community Colleges Foundat · Tempe, AZ · 2024

  Nursing workforce development program.

• $450,000

  Neurotrials Llc · Phoenix, AZ · 2022

  Cerebrospinal fluid analysis with t-gen.

• $420,675

  Neurotrials Llc · Phoenix, AZ · 2024

  Ivy brain tumor center - phoenix sky harbor advertising for clinical trials.

• $380,000

  Society of St Vincent De Paul · Phoenix, AZ · 2023

  Center for family wellness established to focus on the prevention and management of chronic diseases through nutrition, physical activity and overall wellness. Its culturally grounded bilingual education programs encour… read allCenter for family wellness established to focus on the prevention and management of chronic diseases through nutrition, physical activity and overall wellness. Its culturally grounded bilingual education programs encourage the whole family to participate. less
• $368,660

  St Joseph'S Foundation · Phoenix, AZ · 2025

  supports patient care, medical education, research and community outreach at St. Joseph Hospital.

• $300,500

  Swedish Medical Center · Seattle, WA · 2023

  Assess combinations of small molecules and immunotherapies for killing glioblastoma tumor cells in a personalized ex vivo ecosystem with intact tumor microenvironment using multiplex immunochemistry and spatial mapping … read allAssess combinations of small molecules and immunotherapies for killing glioblastoma tumor cells in a personalized ex vivo ecosystem with intact tumor microenvironment using multiplex immunochemistry and spatial mapping of cell types. less
• $300,000

  City of Hope Medical Center · Duarte, CA · 2025

  Dr. Brown - translational adult glioma award. (2nd payment)

• $300,000

  Cleveland Clinic · Cleveland, OH · 2025

  Dr. Yu - translational adult glioma award. (2nd payment)

• $300,000

  Johns Hopkins Hospital · Baltimore, MD · 2025

  Dr. Zhou - translational adult glioma award. (1st payment)

• $300,000

  Massachusetts General · Boston, MA · 2025

  Dr. Badr - translational adult glioma award. (2nd payment)

• $300,000

  Md Anderson Cancer Center · Houston, TX · 2025

  Dr. Calin - translational adult glioma award. (2nd payment)

• $300,000

  Neuro Trials Llc · Phoenix, AZ · 2025

  Dr. Mehta - translational adult giloma award (1st payment)

• $300,000

  Regents of the University of Califo · Oakland, CA · 2025

  Dr. Butowski - translational adult glioma award (2nd payment).

• $300,000

  Regents of University of Michigan · Ann Arbor, MI · 2025

  Dr. Wahl - translational adult giloma award (1st payment)

• $300,000

  Swedish Health Services · Seattle, WA · 2025

  Dr. Puchalski - translational adult glioma award. (2nd payment)

• $300,000

  Translational Genomics Research Tge · Phoenix, AZ · 2025

  Dr. Mike berens - translational adult giloma award (1st payment).

• $300,000

  Children'S Hospital of Philadelphia · Philadelphia, PA · 2024

  Dr. Ma - translational adult glioma award. (2nd and last payment)

• $300,000

  City of Hope Medical Center · Duarte, CA · 2024

  Dr. Brown - translational adult glioma award. (2nd and last payment)

• $300,000

  City of Hope Medical Center · Duarte, CA · 2024

  Dr. Brown - translational adult glioma award. (1st payment)

• $300,000

  Cleveland Clinic · Cleveland, OH · 2024

  Dr. Yu - translational adult glioma award. (1st payment)

• $300,000

  Massachusetts General · Boston, MA · 2024

  Dr. Badr - translational adult glioma award. (1st payment)

• $300,000

  Md Anderson Cancer Center · Houston, TX · 2024

  Dr. Calin - translational adult glioma award. (1st payment)

• $300,000

  Rector Visitors of Univ of Va · Charlottesville, VA · 2024

  Dr. Sheybani - translational adult glioma award. (2nd and last payment)

• $300,000

  Rector Visitors of Univ of Va · Charlottesville, VA · 2024

  Dr. Li - translational adult glioma award. (2nd and last payment)

• $300,000

  Rector Visitors of Univ of Va · Charlottesville, VA · 2024

  Dr. Amounader - translational adult glioma award. (2nd and last payment)

• $300,000

  Regents of the University of Califo · Oakland, CA · 2024

  Dr. Butowski - 2024 translational adult glioma award.

• $300,000

  Swedish Health Services · Seattle, WA · 2024

  Dr. Puchalski - translational adult glioma award. (1st payment)

• $300,000

  Children'S Hospital of Philadelphia · Philadelphia, PA · 2023

  Engineering a multi-antigen targeting car t therapy with confined activites within the tumor microenvironment to treat antigenically heterogenous adult glioblastoma.

• $300,000

  City of Hope Medical Center · Duarte, CA · 2023

  Phase i clinical trial to evaluate the feasibility, safety, and clinical efficacy of tgf-resistant ilira2-car t cells for treatment of recurrent glioblastoma. Pmt #1 of 2.

• $300,000

  Mayo Clinic · Jacksonville, FL · 2023

  Identify the oncogenic signaling dependencies that characterize each of the cellular subpopulations that comprise a glioblastoma tumor, and from this information construct a non-toxic combination of kinase inhibitors to… read allIdentify the oncogenic signaling dependencies that characterize each of the cellular subpopulations that comprise a glioblastoma tumor, and from this information construct a non-toxic combination of kinase inhibitors to effectively treat this disease. Payment 2 of 2. less
• $300,000

  Mayo Clinic College of Medicine · Rochester, MN · 2023

  Evaluate candidate glioma csf proteomic signatures to help understand and monitor glioma evolution in living patients during standard of care and experimental immunotherapy. Payment 2 of 2.

• $300,000

  Memorial Sloan Kettering Cancer Cen · New York, NY · 2023

  Discover and describe dormant tumor cells called cancer stem cells that reside within adult glioma and are resistant to current therapies. Payment 2 of 2.

• $300,000

  Uc San Diego · La Jolla, CA · 2023

  Small molecule regulation of rest protein levels provides an ideal platform for developing a new therapeutic for the treatment of glioblastoma multiforme. Payment 2 of 2.

• $300,000

  University of Tx Md Anderson Cancer · Houston, TX · 2023

  Project seeks to preclinically optimize novel therapeutic approaches for atrx-deficient malignant gliomas targeting g-quadruplex dna secondary structure. Payment 2 of 2.

• $300,000

  University of Virginia · Charlottesville, VA · 2023

  Develop small molecule inhibitors of a newly identified oncogene in glioblastoma. Pmt 1 of 2.

• $300,000

  University of Virginia · Charlottesville, VA · 2023

  Develop and deploy strategies for leveraging mri-guided focused ultrasound therapy to potentiate car-t cell therapy against adult high-grade gliomas. Pmt 1 of 2.

• $300,000

  University of Virginia · Charlottesville, VA · 2023

  Develop and test new therapies for glioblastoma using micornas. Pmt 1 of 2.

• $300,000

  H Lee Moffitt Cancer Center · Rochester, MN · 2022

  In examining the role of tumors cells in modulating bone marrow-derived macrophages and microglia, this study seeks to tailor novel therapeutics for targeting of tumor associated macrophages. Payment 2 of 2.

• $300,000

  Mayo Clinic College of Medicine · Rochester, MN · 2022

  Evaluate candidate glioma csf proteomic signatures to help understand and monitor glioma evolution in living patients during standard of care and experimental immunotherapy. Payment 1 of 2.

• $300,000

  Memorial Sloan Kettering Cancer Cen · New York, NY · 2022

  Discover and describe dormant tumor cells called cancer stem cells that reside within adult glioma and are resistant to current therapies. Payment 1 of 2.

• $300,000

  Swedish Medical Center · Seattle, WA · 2022

  Assess combinations of small molecules and immunotherapies for killing glioblastoma tumor cells in a personalized ex vivo ecosystem with intact tumor microenvironment using multiplex immunochemistry and spatial mapping … read allAssess combinations of small molecules and immunotherapies for killing glioblastoma tumor cells in a personalized ex vivo ecosystem with intact tumor microenvironment using multiplex immunochemistry and spatial mapping of cell types. Payment 1 of 2. less
• $300,000

  Uc San Diego · La Jolla, CA · 2022

  Small molecule regulation of rest protein levels provides an ideal platform for developing a new therapeutic for the treatment of glioblastoma multiforme. Payment 1 of 2.

• $300,000

  Univ of Miami Miller School of Medi · Miami, FL · 2022

  Using patient derived orthotopic xenograft models and a novel immunocompetent model of gbm, the efficacy of a mtl-mmp inhibitor in combination with radiation/tmz will be tested to determine its effects on the immune com… read allUsing patient derived orthotopic xenograft models and a novel immunocompetent model of gbm, the efficacy of a mtl-mmp inhibitor in combination with radiation/tmz will be tested to determine its effects on the immune component of the tumor microenvironment. Payment 2 of 2. less
• $300,000

  Univ of New Mexico Health Sciences · Albuquerque, NM · 2022

  Identify mechanisms underlying inflammatory cell contribution to the emergence of the recurrent tumor by single-cell analysis of residual disease in glioblastoma patients. Payment 2 of 2.

• $300,000

  University of Michigan · Ann Arbor, MI · 2022

  New methods will be developed to measure the activity of tumor metabolic pathways in patients with glioblastoma and to determine whether drugs designed to block these pathways are suitable. Payment 2 of 2.

• $300,000

  University of Tx Md Anderson Cancer · Houston, TX · 2022

  Project seeks to preclinically optimize novel therapeutic approaches for atrx-deficient malignant gliomas targeting g-quadruplex dna secondary structure. Payment 1 of 2.

• $300,000

  Yale Cancer Center · New Haven, CT · 2022

  Use of a novel transformational platform for rapid identification of targets and treatments to inhibit growth and invasion of glioblastoma cells based on rapid patient sample screening using novel nano-engineering techn… read allUse of a novel transformational platform for rapid identification of targets and treatments to inhibit growth and invasion of glioblastoma cells based on rapid patient sample screening using novel nano-engineering techniques. Payment 2 of 2. less
• $298,592

  Indiana University Foundation · Bloomington, IN · 2024

  Dr. Hao - translational adult glioma award. (2nd and last payment)

• $298,592

  Indiana University Foundation · Bloomington, IN · 2023

  Determine the structural basis and molecular mechanism of action of sum01 degraders in treatment of glioblastoma, alone and in combination with current standard chemo and radiotherapy.

• $298,575

  Johns Hopkins Hospital · Baltimore, MD · 2025

  Dr. Raman - translational adult glioma award. (2nd payment)

• $298,575

  Johns Hopkins Hospital · Baltimore, MD · 2024

  Dr. Raman - translational adult glioma award. (1st payment)

• $268,998

  Mayo Clinic · Jacksonville, FL · 2022

  Identify the oncogenic signaling dependencies that characterize each of the cellular subpopulations that comprise a glioblastoma tumor, and from this information construct a non-toxic combination of kinase inhibitors to… read allIdentify the oncogenic signaling dependencies that characterize each of the cellular subpopulations that comprise a glioblastoma tumor, and from this information construct a non-toxic combination of kinase inhibitors to effectively treat this disease. Payment 1 of 2. less
• $250,000

  Fred Hutchison Cancer Research Cent · Seattle, WA · 2025

  Dr gujral - emerging leader award. (2nd payment)

• $250,000

  Johns Hopkins Hospital · Baltimore, MD · 2025

  Dr schreck - emerging leader award. (2nd payment)

• $250,000

  Loyola University of Chicago · Chicago, IL · 2025

  Dr. Wainwright - emerging leader award (1st payment).

• $250,000

  Neuro Trials Llc · Phoenix, AZ · 2025

  Dr. Tovmasyan - emerging leader award (1st payment)

• $250,000

  Stanford University · Stanford, CA · 2025

  Dr. Beinat - emerging leader award (1st payment).

• $250,000

  Stanford University · Stanford, CA · 2025

  Dr. Solomon - emerging leader award (1st payment).

• $250,000

  Fred Hutchison Cancer Research Cent · Seattle, WA · 2024

  Dr gujral - emerging leader award. (1st payment)

• $250,000

  Johns Hopkins Hospital · Baltimore, MD · 2024

  Dr schreck - emerging leader award. (1st payment)

• $250,000

  Regents of University of Michigan · Ann Arbor, MI · 2024

  Dr. Wahl - emerging leader award. (2nd and last payment)

• $250,000

  Columbia University Irving Medical · New York, NY · 2023

  Targeting the glioblastoma master regulator cebp a pharmacokinetics and pharmacodynamics surgical study of st101. Payment 2 of 2.

• $250,000

  University of Michigan · Ann Arbor, MI · 2023

  Develop quantitative methods to assess methionnine metabolism and test the efficacy of methionne-directed therapeutics in mouse models and patients with glioblastoma. Pmt 1 of 2.

• $250,000

  University of Tx Md Anderson Cancer · Houston, TX · 2023

  Develop safe and potent drugs that can turn the tumor immune microenvironment from suppressive to permissive, thereby helping the immune system to recognize and kill glioblastoma. Payment 2 of 2.

• $250,000

  Columbia University Irving Medical · New York, NY · 2022

  Targeting the glioblastoma master regulator cebp a pharmacokinetics and pharmacodynamics surgical study of st101. Payment 1 of 2.

• $250,000

  Society of St Vincent De Paul · Phoenix, AZ · 2022

  Center for family wellness established to focus on the prevention and management of chronic diseases through nutrition, physical activity and overall wellness. Its culturally grounded bilingual education programs encour… read allCenter for family wellness established to focus on the prevention and management of chronic diseases through nutrition, physical activity and overall wellness. Its culturally grounded bilingual education programs encourage the whole family to participate. Payment #3. less
• $250,000

  University of Tx Md Anderson Cancer · Houston, TX · 2022

  Develop safe and potent drugs that can turn the tumor immune microenvironment from suppressive to permissive, thereby helping the immune system to recognize and kill glioblastoma. Payment 1 of 2.

• $250,000

  Vanderbilt University · Nashville, TN · 2022

  Using single-cell and systems biology approaches in glioblastoma, cell subtypes will be mapped to glioblastoma tissues and experimental models, enabling identification and preclinical targeting of interactions between c… read allUsing single-cell and systems biology approaches in glioblastoma, cell subtypes will be mapped to glioblastoma tissues and experimental models, enabling identification and preclinical targeting of interactions between cancer cells, immune cells, and location specific resident brain cells. Payment 2 of 2. less
• $250,000

  Virginia Tech · Roanoke, VA · 2022

  To inhibit tumor cell invasion and invasion, targeted therapeutics will be coupled to biomarker-based imaging in patient-specific models of glioblastoma. Payment 2 of 2.

• $210,430

  Ut Southwestern Medical Center · Dallas, TX · 2022

  Preclinical investigation of focus ultrasound guided delivery to facilitate a lipoprotein-omega-3 fatty acid-based biological therapy in glioblastoma. Payment 2 of 2.

• $208,347

  Mayo Clinic College of Medicine · Rochester, MN · 2022

  Immunostimulatory bacterial antigens expressed in oncolytic viral platforms will be tested in preclinical models of glioblastoma to overcome immune checkpoint inhibitor resistance. Payment 2 of 2.

• $200,000

  Damon Runyon Cancer Research Fdn · New York, NY · 2025

  Dr. John prensner - clinical investigator's award.

• $200,000

  Damon Runyon Cancer Research Fdn · New York, NY · 2024

  Dr. John prensner - clinical investigator's award.

• $200,000

  Neuro Trials Llc · Phoenix, AZ · 2022

  Deposit for ivy brain tumor center building lobby.

• $150,000

  Swedish Medical Center · Seattle, WA · 2024

  High-throughput screening (hts) clinical trial treating recurrent gbm patients.

• $135,000

  St Joseph'S Foundation · Phoenix, AZ · 2023

  supports patient care, medical education, research and community outreach at St. Joseph Hospital.

• $130,500

  Maricopa Community Colleges Foundat · Tempe, AZ · 2023

  The foundation actively seeks contributions from a variety of private sources including individuals, corporations, and foundations and believes that everyone has the opportunity to improve their lives through education.… read allThe foundation actively seeks contributions from a variety of private sources including individuals, corporations, and foundations and believes that everyone has the opportunity to improve their lives through education. MCCCDF works to fulfill this vision with its mission to boldly impact the community through innovative and strategic partnerships for the growth and benefit of the Maricopa Community Colleges, its students, faculty, and staff. less
• $130,000

  Damon Runyon Cancer Research Fdn · New York, NY · 2023

  Investigation of a biomarker phase 2 study to evaluate targeted therapy harboring specific genetic alterations. 4th and final pmt.

• $120,000

  Damon Runyon Cancer Research Fdn · New York, NY · 2022

  Investigation of a biomarker phase 2 study to evaluate targeted therapy harboring specific genetic alterations. Payment 3

• $102,898

  Translational Genomics Research Tge · Phoenix, AZ · 2025

  The ivy neurological sciences internship program

• $101,314

  Translational Genomics Research Tge · Phoenix, AZ · 2024

  2023 - 2024 internship program at tgen designed to give students intensive, hands-on research experience working alongside a mentor-scientist to learn about translational research while investigating questions within th… read all2023 - 2024 internship program at tgen designed to give students intensive, hands-on research experience working alongside a mentor-scientist to learn about translational research while investigating questions within the neurological sciences. less
• $100,218

  Translational Genomics Research Tge · Phoenix, AZ · 2023

  Neurological sciences internship program at tgen designed to give high school and undergraduate students intensive, hands-on research experience working alongside a mentor-scientist to learn about translational research… read allNeurological sciences internship program at tgen designed to give high school and undergraduate students intensive, hands-on research experience working alongside a mentor-scientist to learn about translational research while investigating questions within the neurological sciences. less
• $100,000

  Translational Genomics Research Tge · Phoenix, AZ · 2024

  Mike berens - dipg pediatric glioma research.

• $78,293

  Translational Genomics Research Tge · Phoenix, AZ · 2022

  Neurological sciences internship program at tgen designed to give high school and undergraduate students intensive, hands-on research experience working alongside a mentor-scientist to learn about translational research… read allNeurological sciences internship program at tgen designed to give high school and undergraduate students intensive, hands-on research experience working alongside a mentor-scientist to learn about translational research while investigating questions within neurological sciences. less
• $25,000

  Women'S Board of Barrow Neurologica · Phoenix, AZ · 2025

  Ivy brain tumor center.

View all 153 grants →

Who else funds this kind of work